-transparent.png){kind=logo}
A promising new nucleoside analog, 9-[[2-hydroxy-1-(hydroxymethyl)ethoxy] methyl]-guanine (BW759), which is structurally similar to acyclovir, was tested against acute herpetic keratitis in the rabbit ocular model. Topical 1-0.1% BW759 given 3-5x per day gave beneficial results in that corneal epithelial involvement, conjunctivitis, iritis, and corneal clouding were reduced even when chemotherapy was initiated at 3 days postinoculation. Under the same conditions, topical BW759 therapy gave slightly better results than acyclovir, and both were better than idoxuridine therapy. Mortality rate and colonization of the trigeminal ganglia by HSV-1 were unaffected by BW759 therapy. Duration of virus, shed into the tear film was reduced by BW759.
M D Trousdale, and
A B Nesburn, and
D E Willey, and
H Taaid
July 1983,
Proceedings of the National Academy of Sciences of the United States of America,
M D Trousdale, and
A B Nesburn, and
D E Willey, and
H Taaid
May 1984,
Archives of ophthalmology (Chicago, Ill. : 1960),
M D Trousdale, and
A B Nesburn, and
D E Willey, and
H Taaid
March 1984,
Proceedings of the National Academy of Sciences of the United States of America,
M D Trousdale, and
A B Nesburn, and
D E Willey, and
H Taaid
July 1982,
Antimicrobial agents and chemotherapy,
M D Trousdale, and
A B Nesburn, and
D E Willey, and
H Taaid
July 1986,
Ophthalmic surgery,
M D Trousdale, and
A B Nesburn, and
D E Willey, and
H Taaid
November 1986,
Journal of virology,
M D Trousdale, and
A B Nesburn, and
D E Willey, and
H Taaid
August 1998,
Antimicrobial agents and chemotherapy,
M D Trousdale, and
A B Nesburn, and
D E Willey, and
H Taaid
August 1990,
Antimicrobial agents and chemotherapy,
M D Trousdale, and
A B Nesburn, and
D E Willey, and
H Taaid
June 1983,
American journal of veterinary research,
M D Trousdale, and
A B Nesburn, and
D E Willey, and
H Taaid
April 1985,
Proceedings of the National Academy of Sciences of the United States of America,
